Comparison of Intravitreal Triamcinolone Treatment and Intravitreal Triamcinolone with Grid Laser Treatment in Patients with Diffuse Diabetic Macular Edema

Basit Öğe Kaydı
dc.contributor.authorTufan, Hasan Ali
dc.contributor.authorOzdek, Sengul
dc.contributor.authorHasanreisoglu, Berati
dc.date.accessioned2025-01-27T20:11:45Z
dc.date.available2025-01-27T20:11:45Z
dc.date.issued2012
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.descriptionTOS 41st National Congress of Ophthalmology -- OCT 28-NOV 02, 2007 -- Antalya, TURKEY
dc.description.abstractObjective: To compare the efficacy of intravitreal triamcinolone acetonide (IVTA) and IVTA plus macular laser grid photocoagulation therapy in diffuse diabetic macular edema (DME). Material and Methods: Sixteen patients affected by diffuse DME were retrospectively evaulated. Patients were divided into two groups: control group (IVTA injection) and laser group (IVTA plus grid laser). Main outcomes were best corrected visual aquity (BCVA) and central macular thickness (CMT) at the 3rd and 6th months of treatment. IVTA associated complications and reinjection necessity were assessed. Results: Our study comprised 18 eyes of 16 patients. The baseline BCVA and CMT were 0.93 +/- 0.45 and 530 +/- 136 mu m for the control and 1.02 +/- 0.52 and 509 +/- 177 mu m for the laser group respectively. Posttreatment BCVA at the 3rd and 6th month were 0.73 +/- 0.4 and 0.75 +/- 0.45 for control and 0.98 +/- 0.44 and 1.04 +/- 0.4 for laser group respectively (p>0.05 for all). CMT values at the 3rd and 6th months were 260 +/- 174 mu m (p=0.008) and 362 +/- 163 mu m (p=0.05) for control and 331 +/- 161 mu m (p=0.05) and 388 +/- 215 mu m (p>0.05) for laser groups. 55% of control and 66% of laser groups needed reinjection with an avarage of 7 +/- 4 months after the first injection. 22% cataract progression and 33% intraocular pressure elevation were noted. Conclusion: Macular grid laser photocoagulation after IVTA does not have beneficial effects for diffuse DME.
dc.description.sponsorshipTOS
dc.identifier.doi10.5152/balkanmedj.2012.008
dc.identifier.endpage169
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.issue2
dc.identifier.pmid25206988
dc.identifier.scopus2-s2.0-84863084853
dc.identifier.scopusqualityQ1
dc.identifier.startpage166
dc.identifier.urihttps://doi.org/10.5152/balkanmedj.2012.008
dc.identifier.urihttps://hdl.handle.net/20.500.12428/20709
dc.identifier.volume29
dc.identifier.wosWOS:000315504700011
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofBalkan Medical Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectDiabetic macular edema (DME)
dc.subjectintravitreal triamcinolone (IVTA)
dc.subjectgrid laser
dc.titleComparison of Intravitreal Triamcinolone Treatment and Intravitreal Triamcinolone with Grid Laser Treatment in Patients with Diffuse Diabetic Macular Edema
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu